CLS and Bayer Yakuhin, in collaboration with Sysmex, the Kyoto University Medical Science and Business Liaison Organization (KUMBL), the City of Kobe, and the Foundation for Biomedical Research and Innovation at Kobe (FBRI) together run the annual Kansai Life Science Accelerator Program for nurturing and supporting life science startups in the Kansai region of Japan. Together, we are helping to build a vibrant startup culture to supplement the strong academic programs and mature life science industry in Kansai. Combining a community of healthcare-related businesses, advanced specialty hospitals, and research institutions, we are establishing an ecosystem that creates new technologies and business models in the life sciences.
Experienced US life science business professionals (angel investors, serial entrepreneurs, and industry experts) serve as dedicated advisors for the participating startups, leveraging their real-world experience to help these young companies overcome an array of commercialization challenges. Advisory sessions initially concentrate on the development of a strong business model and later focus on communicating that model to potential investors or strategic partners through presentations. Each program concludes with an opportunity for the participating companies to present to a combined Japanese/US audience.